title: A new opportunity for thalidomide? Further randomised controlled trial are necessary.
authors.forename: Federico
authors.initials: F
authors.lastname: Marchetti
authors.forename: Marzia
authors.initials: M
authors.lastname: Lazzerini
authors.forename: Alessandro
authors.initials: A
authors.lastname: Ventura
mesh_terms: D000293:Adolescent; D002648:Child; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D013792:Thalidomide